ACO-REAL - A Non-interventional Study Providing Insights Into the Use of Acoramidis in Patients With ATTR Amyloidosis With Cardiomyopathy (ATTR-CM) in Routine Clinical Practice
NCT07235462 · RECRUITING · N/A
We track 6 ClinicalTrials.gov studies led by Bayer. The portfolio skews toward N/A (3 trials).
6 clinical trials sponsored by Bayer.
| Phase | Trials | Distribution |
|---|---|---|
| N/A | 3 | 50% |
| Phase 2 | 1 | 17% |
| Phase 1 | 1 | 17% |
| Phase 3 | 1 | 17% |
Bayer currently sponsors 6 clinical trials tracked on ReadTheTrial. These span N/A, Phase 2, Phase 1, Phase 3.
Bayer conducts research across multiple therapeutic areas. Browse the trial listings for details.
Yes, Bayer currently has 3 trials that are actively recruiting participants. Check individual trial pages for eligibility criteria and locations.